SkinHealth Systems Inc. (SKIN) shareholders
Close on Nov 17, 2026Market cap $1.81BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Anthony Davis Joint filing with LCP Edge Holdco, LLC (25.74%), Linden Capital III LLC (25.74%) and 4 more | 33,360,741 | 25.74% | 13D (active) amendment | May 7, 2026 |
| Linden Capital III LLC Joint filing with LCP Edge Holdco, LLC (27.03%), Linden Manager III LP (27.03%) and 4 more | 33,360,741 | 27.03% | 13D (active) amendment | Mar 12, 2024 |
| Capricorn Fund Managers Ltd | 22,276,935 | 17.20% | 13G (passive) amendment | May 15, 2026 |
| Abigail P. Johnson Joint filing with FMR LLC (7.90%) | 10,201,685 | 7.90% | 13G (passive) amendment | Jun 30, 2026 |
| BlackRock Portfolio Management LLC | 7,214,912 | 5.60% | 13G (passive) | Jun 30, 2026 |
| Luxor Capital Group, LP | 1,095,709 | – | 13G (passive) amendment | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SKIN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Capricorn Fund Managers Ltd | 1,113,847 | 0.86% | $15.43M | +143,637 | 1.22% |
| FMR LLC | 510,085 | 0.39% | $7.06M | −349,076 | 0.00% |
| BlackRock, Inc. | 425,810 | 0.33% | $5.90M | +57,930 | 0.00% |
| Millennium Management LLC | 376,847 | 0.29% | $5.22M | +90,974 | 0.00% |
| Vanguard Capital Management LLC | 174,824 | 0.13% | $2.42M | +2,774 | 0.00% |
| Woodline Partners LP | 116,435 | 0.09% | $1.61M | −168,514 | 0.00% |
| Silver Point Capital L.P. | 79,602 | 0.06% | $1.10M | – | 0.10% |
| D. E. Shaw & Co., Inc. | 71,616 | 0.06% | $991.88K | −23,308 | 0.00% |
| Geode Capital Management, LLC | 48,018 | 0.04% | $665.36K | −64,062 | 0.00% |
| UBS Group AG | 41,969 | 0.03% | $581.69K | +29,951 | 0.00% |
| Squarepoint Ops LLC | 33,690 | 0.03% | $466.61K | +18,720 | 0.00% |
| Glendon Capital Management LP | 31,848 | 0.02% | $441.09K | – | 0.06% |
| Prescott Group Capital Management, L.L.C. | 28,887 | 0.02% | $400.08K | −3,072 | 0.03% |
| Vanguard Fiduciary Trust Co | 24,863 | 0.02% | $344.60K | −4,476 | 0.00% |
| Aqr Capital Management LLC | 24,194 | 0.02% | $335.11K | −812 | 0.00% |
| Charles Schwab Investment Management Inc | 20,519 | 0.02% | $284.19K | −15,781 | 0.00% |
| Grimes & Company, Inc. | 20,349 | 0.02% | $281.84K | – | 0.01% |
| State Street Corp | 19,358 | 0.01% | $268.10K | −74,843 | 0.00% |
| Renaissance Technologies LLC | 18,235 | 0.01% | $252.55K | +4,045 | 0.00% |
| Jacobs Levy Equity Management, Inc | 16,369 | 0.01% | $226.71K | −809 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 96 | 3M | 2.6% | 15 / 22 | 42 / 32 | 0M | 1M |
| Q1 2026 | 116 | 4M | 3.0% | 23 / 34 | 37 / 19 | 1M | 1M |
| Q4 2025 | 114 | 4M | 3.1% | 19 / 35 | 38 / 12 | 0M | 0M |
| Q3 2025 | 111 | 4M | 3.0% | 28 / 25 | 34 / 14 | 1M | 0M |
| Q2 2025 | 98 | 4M | 2.9% | 17 / 37 | 26 / 14 | 0M | 1M |
| Q1 2025 | 97 | 4M | 3.2% | 12 / 25 | 35 / 14 | 1M | 0M |
| Q4 2024 | 101 | 4M | 2.8% | 14 / 29 | 30 / 27 | 1M | 1M |
| Q3 2024 | 115 | 4M | 2.8% | 28 / 23 | 39 / 26 | 1M | 1M |
| Q2 2024 | 116 | 4M | 3.1% | 22 / 31 | 41 / 26 | 1M | 1M |
| Q1 2024 | 120 | 5M | 3.5% | 21 / 44 | 37 / 31 | 1M | 1M |
| Q4 2023 | 130 | 5M | 3.5% | 35 / 34 | 43 / 38 | 1M | 2M |
| Q3 2023 | 135 | 5M | 4.0% | 33 / 43 | 40 / 32 | 1M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
102 funds held SKIN in Q1 2026, 50% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of SKIN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Growth Company Fund | 3,375,377 | 2.59% | $2.61M | 0.00% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 2,483,652 | 1.91% | $1.72M | 0.00% | Jun 30, 2026 |
| Vanguard Consumer Staples Index Fund | 967,394 | 0.74% | $748.57K | 0.01% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 925,221 | 0.71% | $640.72K | 0.00% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 591,055 | 0.45% | $457.36K | 0.00% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 410,659 | 0.32% | $317.77K | 0.00% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 355,454 | 0.27% | $275.05K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 145,751 | 0.11% | $112.78K | 0.00% | May 31, 2026 |
| Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | 132,145 | 0.10% | $102.25K | 0.01% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 121,959 | 0.09% | $94.37K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Growth Index Fund | 89,611 | 0.07% | $69.34K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 87,714 | 0.07% | $67.87K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 50,397 | 0.04% | $34.90K | 0.00% | Jun 30, 2026 |
| Small Cap Index Fund | 46,494 | 0.04% | $35.98K | 0.00% | May 31, 2026 |
| Goldman Sachs Absolute Return Tracker Fund | 37,757 | 0.03% | $26.15K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Pedro Bruno Ferreira Malha | President and CEO, Director | 4,667,464 | 3.59% | Oct 13, 2026 |
| Marla Malcolm Beck | President and CEO, Director | 2,753,401 | 2.12% | Apr 11, 2025 |
| Michael P. Monahan | Chief Financial Officer | 1,955,280 | 1.50% | Aug 12, 2026 |
| Sheri Lewis | CSO and COO | 1,584,620 | 1.22% | Apr 13, 2026 |
| Ronald Menezes | Chief Revenue Officer | 1,759,915 | 1.35% | Mar 24, 2026 |
| Kenneth Robert Tripp | Director | – | – | Apr 22, 2026 |
| Edward Scott Beattie | Director | – | – | Apr 22, 2026 |
| Sachin Mahavir Shridharani | Director | 1,500 | 0.00% | Apr 22, 2026 |
| Philippe Schaison | Director | 57,692 | 0.04% | Nov 17, 2025 |
| Brian Christopher Miller | Director | 33,603,776 | 25.82% | Jun 18, 2025 |
| Stephen J. Fanning | Director | 527,283 | 0.41% | Jun 18, 2025 |
| Brent L. Saunders | Director | 8,797,771 | 6.76% | Jun 18, 2025 |
| Desiree Gruber | Director | 192,565 | 0.15% | Jun 18, 2025 |
| Doug K. Schillinger | Director | 216,035 | 0.17% | Jun 18, 2025 |
| Michelle C. Kerrick | Director | 189,813 | 0.15% | Jun 18, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Pedro Bruno Ferreira Malha President and CEO, Director | Oct 9, 2026 | Tax withholding | −78,045 | $0.55 | $42.92K | 4,667,464 |
| Pedro Bruno Ferreira Malha President and CEO, Director | Oct 9, 2026 | Tax withholding | −99,742 | $0.55 | $54.86K | 4,745,509 |
| Michael P. Monahan Chief Financial Officer | Aug 10, 2026 | Tax withholding | −32,357 | $0.64 | $20.71K | 1,955,280 |
| Michael P. Monahan Chief Financial Officer | Apr 9, 2026 | Tax withholding | −26,776 | $0.92 | $24.63K | 1,987,637 |
| Sheri Lewis CSO and COO | Apr 9, 2026 | Tax withholding | −24,904 | $0.92 | $22.91K | 1,584,620 |
| Ronald Menezes Chief Revenue Officer | Mar 20, 2026 | Award | +746,681 | – | – | 1,759,915 |
| Pedro Bruno Ferreira Malha President and CEO, Director | Mar 20, 2026 | Award | +2,654,867 | – | – | 4,845,251 |
| Michael P. Monahan Chief Financial Officer | Mar 20, 2026 | Award | +746,681 | – | – | 2,014,413 |
| Sheri Lewis CSO and COO | Mar 20, 2026 | Award | +746,681 | – | – | 1,609,524 |
| Michael P. Monahan Chief Financial Officer | Mar 17, 2026 | Tax withholding | −58,573 | $1.17 | $68.53K | 1,267,732 |
| Sheri Lewis CSO and COO | Mar 17, 2026 | Tax withholding | −51,883 | $1.17 | $60.70K | 862,843 |
| Ronald Menezes Chief Revenue Officer | Mar 17, 2026 | Tax withholding | −61,471 | $1.17 | $71.92K | 1,013,234 |
| Philippe Schaison Director | Nov 13, 2025 | Award | +57,692 | – | – | 57,692 |
| Ronald Menezes Chief Revenue Officer | Nov 1, 2025 | Tax withholding | −46,426 | $1.43 | $66.39K | 1,074,705 |
| Pedro Bruno Ferreira Malha President and CEO, Director | Oct 9, 2025 | Award | +1,228,846 | $1.56 | $1.92M | 1,228,846 |
| Pedro Bruno Ferreira Malha President and CEO, Director | Oct 9, 2025 | Award | +961,538 | $1.56 | $1.50M | 2,190,384 |
| Michael P. Monahan Chief Financial Officer | Aug 10, 2025 | Tax withholding | −32,357 | $1.89 | $61.15K | 1,326,305 |
| Doug K. Schillinger Director | Jun 16, 2025 | Award | +73,051 | – | – | 216,035 |
| Michelle C. Kerrick Director | Jun 16, 2025 | Award | +73,051 | – | – | 189,813 |
| Brian Christopher Miller Director | Jun 16, 2025 | Award | +73,051 | – | – | 243,035 |
| Brent L. Saunders Director | Jun 16, 2025 | Award | +73,051 | – | – | 5,994,820 |
| Desiree Gruber Director | Jun 16, 2025 | Award | +73,051 | – | – | 192,565 |
| Stephen J. Fanning Director | Jun 16, 2025 | Award | +73,051 | – | – | 527,283 |
| Michael P. Monahan Chief Financial Officer | Jun 1, 2025 | Tax withholding | −24,290 | $1.63 | $39.59K | 1,358,662 |
| Michael P. Monahan Chief Financial Officer | Apr 9, 2025 | Tax withholding | −26,776 | $1.08 | $28.92K | 1,382,952 |
| Sheri Lewis CSO and COO | Apr 9, 2025 | Tax withholding | −31,296 | $1.08 | $33.80K | 914,726 |
| Marla Malcolm Beck President and CEO, Director | Apr 9, 2025 | Tax withholding | −92,981 | $1.08 | $100.42K | 2,753,401 |
| Michael P. Monahan Chief Financial Officer | Mar 17, 2025 | Award | +639,204 | $1.32 | $843.75K | 1,409,728 |
| Sheri Lewis CSO and COO | Mar 17, 2025 | Award | +639,204 | $1.32 | $843.75K | 946,022 |
| Marla Malcolm Beck President and CEO, Director | Mar 17, 2025 | Award | +1,832,386 | $1.32 | $2.42M | 2,846,382 |
| Ronald Menezes Chief Revenue Officer | Mar 17, 2025 | Award | +639,204 | $1.32 | $843.75K | 1,121,131 |
| Michael P. Monahan Chief Financial Officer | Dec 1, 2024 | Tax withholding | −24,227 | $1.48 | $35.86K | 770,524 |
| Desiree Gruber Director | Nov 20, 2024 | Sale | −14,663 | $1.50 | $21.99K | 119,514 |
| Brent L. Saunders Director | Aug 12, 2024 | Buy | +40,450 | $1.08 | $43.69K | 5,921,769 |
| Michael P. Monahan Chief Financial Officer | Aug 10, 2024 | Tax withholding | −32,274 | $1.12 | $36.15K | 794,751 |
| Doug K. Schillinger Director | Jul 8, 2024 | Award | +78,534 | – | – | 142,984 |
| Brian Christopher Miller Director | Jul 8, 2024 | Award | +78,534 | – | – | 169,984 |
| Michelle C. Kerrick Director | Jul 8, 2024 | Award | +78,534 | – | – | 116,762 |
| Julius Few Director | Jul 8, 2024 | Award | +78,534 | – | – | 194,341 |
| Desiree Gruber Director | Jul 8, 2024 | Award | +78,534 | – | – | 134,177 |
| Brent L. Saunders Director | Jul 8, 2024 | Award | +78,534 | – | – | 5,881,319 |
| Michael D. Capellas Director | Jul 8, 2024 | Award | +78,534 | – | – | 276,146 |
| Michael P. Monahan Chief Financial Officer | Apr 9, 2024 | Award | +292,207 | – | – | 827,025 |
| Marla Malcolm Beck President and CEO, Director | Apr 9, 2024 | Award | +837,662 | – | – | 1,078,214 |
| Daniel Copell Watson Chief Revenue Oficer | Apr 9, 2024 | Award | +243,506 | – | – | 808,620 |
| Marla Malcolm Beck President and CEO, Director | Apr 8, 2024 | Tax withholding | −21,439 | $3.80 | $81.47K | 1,013,996 |
| Daniel Copell Watson Chief Revenue Oficer | Apr 5, 2024 | Tax withholding | −11,212 | $3.71 | $41.60K | 778,112 |
| Marla Malcolm Beck President and CEO, Director | Mar 20, 2024 | Tax withholding | −10,720 | $4.36 | $46.74K | 1,035,435 |
| Daniel Copell Watson Chief Revenue Oficer | Mar 1, 2024 | Tax withholding | −6,356 | $3.73 | $23.71K | 789,324 |
| Marla Malcolm Beck President and CEO, Director | Feb 20, 2024 | Tax withholding | −10,720 | $2.98 | $31.95K | 1,046,155 |
| Daniel Copell Watson Chief Revenue Oficer | Feb 4, 2024 | Tax withholding | −10,633 | $2.98 | $31.69K | 795,680 |
| Marla Malcolm Beck President and CEO, Director | Jan 20, 2024 | Tax withholding | −10,663 | $2.43 | $25.91K | 1,056,875 |
| Marla Malcolm Beck President and CEO, Director | Dec 20, 2023 | Tax withholding | −10,676 | $3.18 | $33.95K | 1,067,538 |
| Daniel Copell Watson Chief Revenue Oficer | Nov 29, 2023 | Award | +156,250 | – | – | 565,114 |
| Bradley Hauser Chief Operating Officer | Nov 29, 2023 | Award | +176,711 | – | – | 390,632 |
| Michael P. Monahan Chief Financial Officer | Nov 29, 2023 | Award | +176,711 | – | – | 534,818 |
| Marla Malcolm Beck Interim CEO, Director | Nov 20, 2023 | Award | +213,675 | – | – | 240,552 |
| Brian Christopher Miller Director | Aug 17, 2023 | Buy | +60,000 | $5.81 | $348.60K | 91,450 |
| Michael D. Capellas Director | Aug 17, 2023 | Buy | +30,000 | $6.03 | $180.90K | 197,612 |
| Michael P. Monahan Chief Financial Officer | Aug 17, 2023 | Buy | +5,000 | $6.02 | $30.10K | 358,107 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of SkinHealth Systems's stock actually held short. Settlement fails (shares not delivered on time) peaked at 93,943 shares on Oct 13, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Ronald Menezes Former Officer | May 20, 2026 | 165,000 | $114.53K | May 20, 2026 | Restricted Stock Vesting |
| Marla Malcolm Beck Former Officer & Director | Dec 5, 2025 | 5,000 | $8.07K | Dec 5, 2025 | Restricted Stock Vesting |
| Paul Bokota General Counsel | Jul 1, 2025 | 12,000 | $19.20K | Jun 6, 2025 | Restricted Stock Units |
See a number that looks wrong?